General Information of Drug (ID: DR3401)
Drug Name
Acadesine
Synonyms AICAR; Acadra; ADV-P1; ATH-001; Acadesine (intravenous formulation, leukemia); Acadesine (intravenous formulation, leukemia), Advanced In Vitro Cell Technologies
Indication Diabetic complication [ICD11: 5A2Y] Phase 3 [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 258.23 Topological Polar Surface Area 157
Heavy Atom Count 18 Rotatable Bond Count 3
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 7
Cross-matching ID
PubChem CID
17513
ChEBI ID
CHEBI:28498
CAS Number
2627-69-2
TTD Drug ID
D0R3MT
Formula
C9H14N4O5
Canonical SMILES
C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N
InChI
InChI=1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1
InChIKey
RTRQQBHATOEIAF-UUOKFMHZSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
ZMP DM015037
65110
Unclear - Unclear 1 [2]
AMPK DM019115 N. A. Unclear - Unclear 2 [2]
IMP DM001534
135398640
Unclear - Unclear 2 [2]
Adenosine Phosphate DM000018
6083
Unclear - Unclear 3 [2]
ATP generation DM019116 N. A. Unclear - Unclear 3 [2]
Adenosine DM003051
60961
Unclear - Unclear 4 [2]
AMPK DM019115 N. A. Unclear - Unclear 4 [2]
Ischaemic injuury DM019117 N. A. Unclear - Unclear 4 [2]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR011567 Acadesine ZMP Unclear - Unclear Unclear [2]
MR011568 ZMP IMP Unclear - Unclear Unclear [2]
MR011572 ZMP AMPK Unclear - Unclear Unclear [2]
MR011573 AMPK ATP generation Unclear - Unclear Unclear [2]
MR011569 IMP AMP Unclear - Unclear Unclear [2]
MR011570 AMP Adenosine Unclear - Unclear Unclear [2]
MR011571 AMP AMPK Unclear - Unclear Unclear [2]
MR011574 ATP generation Ischaemic injuury Unclear - Unclear Unclear [2]
⏷ Show the Full List of 8 MR(s)
References
1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5133).
2 A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.